1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AUROBINDO PHARMA LTD.
Aurobindo Pharma Ltd.
NSE: AUROPHARMA | BSE: 524804
1660.00 -19.80 (-1.18%)
447.0K
NSE+BSE Volume

NSE 15 Sep, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Aurobindo Pharma gets US FDA nod for Beclomethasone HFA Inhaler, targeting a $301 million market See details